Assessment of the impact of model-based scatter correction on [ 18F]-FDG 3D brain PET in healthy subjects using statistical parametric mapping

NeuroImage

Volumn 20, Issue 3, 2003, Pages 1848-1856

  Montandon, Marie Louise ^a   Slosman, Daniel O ^a   Zaidi, Habib ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Brain imaging; PET; Scatter correction; Statistical parametric mapping

Indexed keywords

FLUORODEOXYGLUCOSE F 18; OXYGEN 15; WATER;

ADULT; AGED; ALGORITHM; ARTICLE; ATTENUATION; BRAIN MAPPING; BRAIN METABOLISM; BRAIN STEM; BRAIN TISSUE; CALCULATION; CEREBELLUM; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN EXPERIMENT; IMAGE RECONSTRUCTION; INSULA; INTERMETHOD COMPARISON; MALE; MODEL; NORMAL HUMAN; PHANTOM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SIMULATION; STATISTICAL PARAMETERS; TEMPORAL CORTEX; TEMPORAL LOBE; THALAMUS; THREE DIMENSIONAL IMAGING;

EID: 0345414979     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2003.07.013     Document Type: Article

References (27)

1. Bailey D.L. Quantitative procedures in 3D PET. Bendriem B., Townsend D.W. The Theory and Practice of 3D PET. 1998;55-109 Kluwer Academic Publishers, Dordrecht.
2. Berding G., Odin P., Brooks D.J., et al. Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET. Mov. Disord. 16:2001;1014-1022.
3. Cherry S.R., Dahlbom M., Hoffman E.J. 3D PET using a conventional multislice tomograph without septa. J. Comput. Assist. Tomogr. 15:1991;655-668.
4. Friston, K., Ashburner, J., Heather, J., et al., 1999. "Statistical Parametric Mapping." Available at: www.fil.ion.ucl.ac.uk/spm (The Wellcome Department of Cognitive Neurology, University College London, London).
5. Friston K., Holmes A., Worsley K., et al. Statistical parametric maps in functional imaging a general linear approach . Hum. Brain Mapp. 2:1995;189-210.
6. Gispert, J.D., Pascau, J., Reig, S., et al., 2003. Influence of the normalization template on the outcome of statistical parametric mapping of PET scans. NeuroImage 18, 601-612.
7. 18F-FDG PET in localization of frontal lobe epilepsy comparison of visual and SPM analysis . J. Nucl. Med. 43:2002;1167-1174.
8. Kinahan P.E., Rogers J.G. Analytic 3D image reconstruction using all detected events. IEEE Trans. Nucl. Sci. 36:1989;964-968.
9. Loessner A., Alavi A., Lewandrowski K.U., et al. Regional cerebral function determined by FDG-PET in healthy volunteers normal patterns and changes with age . J. Nucl. Med. 36:1995;1141-1149.
10. Matsuda H., Kanetaka H., Ohnishi T., et al. Brain SPET abnormalities in Alzheimer's disease before and after atrophy correction. Eur. J. Nucl. Med. Mol. Imaging. 29:2002;1502-1505.
11. Michel, C., Sibomana, M., Boi, A., et al., 1998. Preserving poisson characteristics of PET data with weighted OSEM reconstruction, in: Proceedings of the IEEE Nuclear Science Symposium and Medical Imaging Conference, IEEE, Toronto, Canada, pp. 1323-1329.
12. Piert M., Koeppe R.A., Giordani B., et al. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET. J. Nucl. Med. 37:1996;201-208.
13. Reinders A.A., Paans A.M., de Jong B.M., et al. Iterative versus filtered backprojection reconstruction for statistical parametric mapping of PET activation measurements a comparative case study . NeuroImage. 15:2002;175-181.
14. Schoenahl, F., Montandon, M.-L., Slosman, D., Zaidi, H., 2003. Assessment of the performance of SPM analysis in PET neuroactivation studies: a Monte Carlo investigation, in: Conference Proceedings of the VIIth International Meeting on Fully Three-dimensional Image Reconstruction in Radiology and Nuclear Medicine, 29 June-4 July 2003, Saint-Malo, France. Available at: http://dmnu-pet5.hcuge.ch.
15. 123I-IMP brain perfusion SPET with the triple energy window method in normal subjects using SPM analysis. Eur. J. Nucl. Med. 29:2002;342-345.
16. Signorini M., Paulesu E., Friston K., et al. Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET a clinical validation of statistical parametric mapping . NeuroImage. 9:1999;63-80.
17. 99mTc-HMPAO retention . Brain Res. Rev. 36:2001;230-240.
18. Stodilka R.Z., Kemp B.J., Prato F.S., Nicholson R.L. Importance of bone attenuation in brain SPECT quantification. J. Nucl. Med. 39:1998;190-197.
19. Talairach J., Tournoux P. Co-Planar Atlas of the Human Brain. 1988;Thieme Medical Publishers, New York.
20. 99mTc static line sources anthropomorphic dosimetry studies and influence on brain quantification . J. Nucl. Med. 41:2000;2051-2062.
21. Van Laere K.J., Versijpt J., Koole M., et al. Experimental performance assessment of SPM for SPECT neuroactivation studies using a subresolution sandwich phantom design. Neuroimage. 16:2002;200-216.
22. Watson C.C., Newport D., Casey M.E., et al. Evaluation of simulation-based scatter correction for 3-D PET cardiac imaging. IEEE Trans. Nucl. Sci. 44:1997;90-97.
23. Worsley K.J., Marrett S., Neelin P., et al. A unified statistical approach for determining significant signals in images of cerebral activation. Hum. Brain Mapp. 4:1996;58-73.
24. Zaidi H. Comparative evaluation of scatter correction techniques in 3D positron emission tomography. Eur. J. Nucl. Med. 27:2000;1813-1826.
25. Zaidi H. Scatter modelling and correction strategies in fully 3D PET. Nucl. Med. Commun. 22:2001;1181-1184.
26. Zaidi H., Montandon M.-L. Which attenuation coefficient to use in combined attenuation and scatter corrections for quantitative brain SPET? Eur. J. Nucl. Med. 29:2002;967-969.
27. Zaidi, H., Sossi, V., 2003. Correction for image degrading factors is essential for accurate quantification of brain function using PET. Med. Phys. 30, In press.